COVID-19: Hydroxychloroquine prophylaxis is just a prophylaxis! Be careful and perceive it right.
作者信息
Garg Rakesh, Chakraborty Raunaq
机构信息
Department of Onco-Anaesthesia and Palliative Medicine, Dr. BRAIRCH, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
出版信息
J Anaesthesiol Clin Pharmacol. 2022 Jul;38(Suppl 1):S139-S140. doi: 10.4103/joacp.JOACP_423_20. Epub 2022 Feb 3.
Abstract
摘要
相似文献
1
COVID-19: Hydroxychloroquine prophylaxis is just a prophylaxis! Be careful and perceive it right.新冠病毒肺炎：羟氯喹预防只是一种预防措施！谨慎对待并正确认识它。
J Anaesthesiol Clin Pharmacol. 2022 Jul;38(Suppl 1):S139-S140. doi: 10.4103/joacp.JOACP_423_20. Epub 2022 Feb 3.
2
Impact of Prophylactic Hydroxychloroquine on People at High Risk of COVID-19: A Systematic Review and Meta-Analysis.预防性羟氯喹对2019冠状病毒病高危人群的影响：一项系统评价和荟萃分析。
J Clin Med. 2021 Jun 13;10(12):2609. doi: 10.3390/jcm10122609.
3
Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?羟氯喹作为 COVID-19 的预防或治疗药物：证据说了什么？
Indian J Public Health. 2020 Jun;64(Supplement):S125-S127. doi: 10.4103/ijph.IJPH_496_20.
4
Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial.羟氯喹作为医护人员新冠病毒病暴露前预防用药：一项随机试验
medRxiv. 2020 Sep 18:2020.09.18.20197327. doi: 10.1101/2020.09.18.20197327.
5
Use of hydroxychloroquine and interferon alpha-2b for the prophylaxis of COVID-19.使用羟氯喹和干扰素 α-2b 预防 COVID-19。
Med Hypotheses. 2020 Nov;144:109802. doi: 10.1016/j.mehy.2020.109802. Epub 2020 May 20.
6
Hydroxychloroquine as antiviral prophylaxis for exposed caregivers to Covid-19: An urgent appraisal is needed.羟氯喹作为暴露于新冠病毒的护理人员的抗病毒预防用药：需要紧急评估。
J Infect Public Health. 2020 Jun;13(6):865-867. doi: 10.1016/j.jiph.2020.05.005. Epub 2020 May 11.
7
Finding the Dose for Hydroxychloroquine Prophylaxis for COVID-19: The Desperate Search for Effectiveness.寻找羟氯喹预防 COVID-19 的剂量：对有效性的迫切探索。
Clin Pharmacol Ther. 2020 Oct;108(4):766-769. doi: 10.1002/cpt.1874. Epub 2020 Jun 1.
8
Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.羟氯喹用于接触新冠病毒疾病（COVID-19）后成年人暴露者预防严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染的暴露后预防效果：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):475. doi: 10.1186/s13063-020-04446-4.
9
COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020.2020 年法国长期接受羟氯喹治疗的类肉瘤病患者中的 COVID-19 病例。
Emerg Infect Dis. 2020 Oct;26(10):2513-2515. doi: 10.3201/eid2610.201816. Epub 2020 Jul 1.
10
Can post-exposure prophylaxis for COVID-19 be considered as an outbreak response strategy in long-term care hospitals?在长期护理医院，COVID-19 的暴露后预防可否被视为疫情应对策略？
Int J Antimicrob Agents. 2020 Jun;55(6):105988. doi: 10.1016/j.ijantimicag.2020.105988. Epub 2020 Apr 17.
本文引用的文献
1
The COVID-19 hydroxychloroquine prophylaxis perception of Indian anesthesiologists: A survey-based original article.印度麻醉医师对新冠病毒羟氯喹预防的认知：一项基于调查的原创文章
J Anaesthesiol Clin Pharmacol. 2020 Oct-Dec;36(4):471-476. doi: 10.4103/joacp.JOACP_379_20. Epub 2020 Nov 5.
2
Students' perception of the educational environment in medical college: a study based on DREEM questionnaire.医学生对医学院校教育环境的认知：一项基于DREEM问卷的研究。
Korean J Med Educ. 2016 Sep;28(3):281-8. doi: 10.3946/kjme.2016.32. Epub 2016 Jun 30.
3
Attitudes and perceptions about clinical guidelines: a qualitative study with Spanish physicians.对临床指南的态度和看法：一项针对西班牙医生的定性研究。
PLoS One. 2014 Feb 5;9(2):e86065. doi: 10.1371/journal.pone.0086065. eCollection 2014.
4
Evidence-based medicine: revisiting the pyramid of priorities.循证医学：重新审视优先事项金字塔。
J Bodyw Mov Ther. 2012 Jan;16(1):42-9. doi: 10.1016/j.jbmt.2011.05.003. Epub 2011 Jun 24.
Zotero 插件